Improve CO₂ Reagent Stability, Accuracy, and Manufacturing Efficiency

Introduction

Are you facing these common challenges during CO₂ assay kit development?

• Unstable reagent blanks and significant sensitivity loss after accelerated stability testing
• Sample result deviations exceeding QC requirements
• Precipitation after enzyme reconstitution and poor open-vial stability
• Shortened shelf life and repeated formulation failures
• Interference from contaminating enzymes extending optimization cycles

As the core enzyme in enzymatic CO₂ assays, Phosphoenolpyruvate Carboxylase (PEPC) directly impacts assay stability, sensitivity, and commercialization potential.

Hzymes has developed a next-generation PEPC specifically optimized for CO₂ diagnostic reagents. Backed by validated performance data, this recombinant microbial-derived PEPC addresses the major challenges in IVD reagent development, helping manufacturers accelerate formulation optimization, improve assay robustness, and reduce production risks.

Figure 1. Reaction Principle of PEPC-Based CO₂ Enzymatic Assay

What Is PEPC and Why Is It Critical for CO₂ Assays?

Blood CO₂ concentration is an important clinical indicator for evaluating acid-base balance disorders and respiratory function abnormalities. In enzymatic CO₂ detection systems, PEPC serves as the core catalytic engine.

Unlike conventional plant-derived PEPC, Hzymes recombinant microbial PEPC:

• Requires only Mg²⁺ as a cofactor
• Does not require expensive activators such as:
  • Acetyl-CoA
  • Fructose-1,6-bisphosphate
  • Glucose-6-phosphate

The enzyme efficiently catalyzes the carboxylation of bicarbonate with PEP (or the more stable PEP·3CHA substrate). When coupled with Malate Dehydrogenase (MDH), the assay quantitatively measures CO₂ concentration by monitoring the consumption of NADH (or the more stable APADH).

This enzymatic coupling system has become the mainstream solution for single-reagent CO₂ assays due to its speed, specificity, and compatibility with automated chemistry analyzers.

Table 1. Overview of Key PEPC Parameters

Key Challenges in CO₂ Reagent Development

1. Poor Stability Limits Shelf Life

Single-reagent CO₂ assays place high stability demands on both substrates (PEP and NADH) and enzymes (PEPC and MDH). Many commercially available PEPC enzymes exhibit insufficient thermal stability, resulting in assay shelf lives shorter than six months.

2. Contaminating Enzymes Cause Accuracy Issues

Residual contaminating enzymes such as:

• Pyruvate Kinase (PK)
• Lactate Dehydrogenase (LDH)

can trigger non-specific reactions and excessive substrate consumption, leading to:

• Large fluctuations in reagent blank absorbance
• Sensitivity drift after accelerated testing
• Clinical sample bias beyond ±10%

These issues significantly increase formulation optimization time.

3. Poor Formulation Compatibility Increases Development Complexity

Many PEPC products demonstrate limited tolerance toward common reagent components such as:

• EDTA
• Borates
• Surfactants
• Preservatives

As a result, enzyme activity declines rapidly during accelerated stability studies, forcing repeated reformulation efforts.

Hzymes Next-Generation PEPC: Engineered for CO₂ Diagnostic Reagents

Through advanced strain screening, process optimization, and extensive reagent validation, Hzymes has developed a PEPC enzyme specifically tailored for CO₂ assay applications.

All key performance parameters are experimentally verified and traceable.

Advantage 1: Excellent Stability for Long Shelf-Life CO₂ Reagents

Compared with competing products, Hzymes PEPC demonstrates superior:

• Optimal pH performance
• pH stability
• Thermal stability
• Km characteristics

Accelerated Stability Performance

• ≥90% residual activity after 7 days at 37°C (lyophilized powder)
• ≥85% residual activity after 30 minutes at 47°C (enzyme solution)
• Stable below 45°C for transportation and storage robustness

Long-Term Stability

• ≥90% residual activity after 12 months at -20°C

Excellent Solubility

• Clear solution without precipitation after reconstitution at 10 mg/mL

Practical Benefits

Because the enzyme requires only Mg²⁺ as a cofactor and remains highly stable around pH 8.0, it is ideal for long-shelf-life single-reagent CO₂ systems.

Manufacturers can reduce formulation complexity without relying on excessive stabilizers while supporting shelf lives up to 12 months.

Table 2. Performance Advantages of PEPC

Advantage 2: Strict Quality Control Minimizes Detection Bias

Hzymes applies rigorous purification and QC processes to reduce contaminating enzyme activity.

Quality Specifications

• SDS-PAGE purity: ≥90%
• Protein specific activity: ≥120 U/mg

Residual Contaminating Enzyme Levels

• Pyruvate Kinase (PK): ≤0.05%
• Lactate Dehydrogenase (LDH): ≤0.001%
• NADH Oxidase (NOX): ≤0.001%

Practical Benefits

Residual PK can consume PEP substrate and significantly reduce long-term reagent stability.

By minimizing endogenous contaminating enzymes during purification, Hzymes PEPC improves:

• Accelerated stability performance
• Long-term storage stability
• Batch-to-batch consistency
• Clinical testing accuracy

Advantage 3: Broad Formulation Compatibility for Faster Development

Through sequence engineering and formulation optimization, Hzymes PEPC demonstrates excellent tolerance toward a wide range of chemical components commonly used in IVD reagents.

Surfactant Compatibility

Compatible with:

• 0.1% Triton X-100
• 0.1% Brij 35
• 0.1% Tween 20
• 0.1% Sodium cholate

Metal Ions and Chelators

Tolerant to:

• Ferric chloride
• Cobalt chloride
• Manganese chloride
• Zinc sulfate
• Nickel sulfate
• Iodoacetamide
• Hydroxylamine
• EDTA
• Borates
• Sodium fluoride

Preservative Compatibility

• Excellent tolerance to sodium azide
• No significant activity loss during long-term storage

Practical Benefits

Hzymes PEPC can directly replace existing PEPC raw materials in many formulations without requiring major reformulation, helping manufacturers shorten R&D timelines and accelerate commercialization.

Table 3. Chemical Compatibility Evaluation Data (1 mg/mL, 37°C, 1 Day)

Proven Performance in CO₂ Reagent Systems

Hzymes PEPC has been validated in complete single-reagent CO₂ assay systems with excellent overall performance.

Wide Linear Range

• Excellent correlation from 0–57 mM (R > 0.990)

High Accuracy and Precision

• QC performance within target ranges
• Within-run precision: CV = 1%
• Strong correlation with leading international brands before and after accelerated testing (R > 0.990)

Clinical Bias Performance

• ≤10 mmol/L: |B|max ≤1

• 10 mmol/L: |B%|max ≤10%

• Average bias <5%

Figure 2. Correlation of Method Comparison Results Before and After Accelerated Stability Testing at 37°C

Strong Anti-Interference Performance

Tolerant to common serum interferents:

• Hemoglobin: ≤800 mg/dL
• Bilirubin: ≤80 mg/dL
• Vitamin C: ≤60 mg/dL
• Lipemia: ≤1000 mg/dL

Detection bias remained within ±5.0%.

Table 4. Anti-Interference Performance Data of Single-Reagent CO₂ Assay

Excellent Accelerated and Open-Vial Stability

After accelerated testing at 37°C for 10 days:

• Better sensitivity retention
• Better enzyme activity retention
• Better QC performance than competing products

Open-vial onboard refrigerated stability remained compliant after 14 days.

Excellent Batch Consistency

• Low batch-to-batch variation
• High reproducibility

Hzymes PEPC for Reliable CO₂ Diagnostic Manufacturing

Hzymes PEPC is designed specifically for modern CO₂ assay development, offering:

• High thermal stability
• Low contaminating enzyme activity
• Broad formulation compatibility
• Excellent clinical performance
• Long-term storage stability

Whether you are developing new CO₂ diagnostic reagents or optimizing existing formulations, Hzymes PEPC helps improve assay reliability, reduce development risk, and support scalable manufacturing.

Related Products